Notice on discontinuation of the supply chain with Reglan 10 mg/2 ml solution for injection (metoclopramide)
12.02.2015
Alkaloid d.o.o., the marketing authorisation holder for Reglan 10 mg/2 ml solution for injection (metoclopramide) has notified the Agency for Medicinal Products and Medical Devices on the permanent discontinuation of the supply chain with this medicinal product. The decision on discontinuation of the supply chain is due to commercial reasons and is not linked with the quality, efficacy or safe use of the medicinal product.
There is no other authorised medicinal product with the same dosage form containing this active substance and HALMED will, at wholesaler’s request, for treatment of patients in healthcare settings or in the case of named patient prescriptions authorise the enter of medicinal products not authorised in Croatia.
